Key facts
- This page summarizes Moll Laurent R.'s Form 4 filing for Arteris, Inc. (AIP).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Feb 2025, 18:47.
Moll Laurent R. - 21 Feb 2025 Form 4 Insider Report for Arteris, Inc. (AIP)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- AIP
- Reported as of
- 21 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Feb 2025, 18:47:50 UTC
- Prior SEC filing
- 08 Jan 2025
- Next SEC filing
- 04 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Paul Alpern, as Attorney-in-Fact for Moll Laurent R
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Moll Laurent R. filed Form 4 for Arteris, Inc. (AIP) on 25 Feb 2025.
Change
- Previous filing in this sequence was filed on 08 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AIP
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +37,783
- Change %
- +8.4%
- Price
- $0.000000
- Shares after
- 488,383
- Date
- 21 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AIP
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- $0
- Shares
- +40,000
- Change %
- Price
- $0.000000
- Shares after
- 40,000
- Date
- 21 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- $9.28
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Includes 37,783 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in16 substantially equal quarterly installments commencing on April 1, 2025.
Footnote F2
40,000 of the shares subject to the stock option vest and become exercisable in 16 substantially equal quarterly installments commencing on April 1, 2025.